Canntab Therapeutics Limited
Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.
Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
PILL |
$89,380
|
96.95% |
$0.6150
|
| CTABF |
Total volume
$2,810
|
3.05% |
Stock price
$0.6160
|
